Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Teitel

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Thrombosis and Haemostasis|November 1, 1991
The factor VIII bypassing activity of prothrombin complex concentrates: the roles of factor VIIa and of endothelial cell tissue factorJ M Teitel
Canadian Family Physician Medecin De Famille Canadien|February 1, 2011
Anticoagulant therapyJ M Teitel
Annals of Medicine|November 22, 2000
Viral safety of haemophilia treatment productsJ M Teitel
Clinical and Laboratory Haematology|March 17, 2001
Unexpected bleeding disorders: Algorithm for approach to therapyJ M Teitel
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Safety of coagulation factor concentratesJ M Teitel
Journal of Cellular Physiology|August 1, 1986
Specific inhibition of endothelial cell proliferation by isolated endothelial plasma membranesJ M Teitel
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
National haemophilia treatment protocols: CanadaJ M Teitel
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 22, 1999
Recombinant factor VIIa versus aPCCs in haemophiliacs with inhibitors: treatment and cost considerationsJ M Teitel
Clinical and Laboratory Haematology|March 17, 2001
Clinical approach to the patient with unexpected bleedingJ M Teitel
The Journal of Clinical Investigation|May 1, 1983
Protection of factor Xa from neutralization by the heparin-antithrombin complexJ M Teitel, R D Rosenberg
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Thrombosis and Haemostasis|November 1, 1991
The factor VIII bypassing activity of prothrombin complex concentrates: the roles of factor VIIa and of endothelial cell tissue factorJ M Teitel
Canadian Family Physician Medecin De Famille Canadien|February 1, 2011
Anticoagulant therapyJ M Teitel
Annals of Medicine|November 22, 2000
Viral safety of haemophilia treatment productsJ M Teitel
Clinical and Laboratory Haematology|March 17, 2001
Unexpected bleeding disorders: Algorithm for approach to therapyJ M Teitel
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Safety of coagulation factor concentratesJ M Teitel
Journal of Cellular Physiology|August 1, 1986
Specific inhibition of endothelial cell proliferation by isolated endothelial plasma membranesJ M Teitel
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
National haemophilia treatment protocols: CanadaJ M Teitel
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 22, 1999
Recombinant factor VIIa versus aPCCs in haemophiliacs with inhibitors: treatment and cost considerationsJ M Teitel
Clinical and Laboratory Haematology|March 17, 2001
Clinical approach to the patient with unexpected bleedingJ M Teitel
The Journal of Clinical Investigation|May 1, 1983
Protection of factor Xa from neutralization by the heparin-antithrombin complexJ M Teitel, R D Rosenberg
Pageof 4